Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

The genetic and environmental causes of pulmonary fibrosis.

Macneal K, Schwartz DA.

Proc Am Thorac Soc. 2012 Jul;9(3):120-5. doi: 10.1513/pats.201112-055AW. Review. Erratum in: Proc Am Thorac Soc. 2013 Jun;10(3):278.

PMID:
22802285
2.

MUC5B promoter polymorphism and pulmonary fibrosis.

Zhang GY, Liao T, Gao WY.

N Engl J Med. 2011 Jul 14;365(2):178; author reply 178-9. doi: 10.1056/NEJMc1105707#SA1. No abstract available.

PMID:
21751917
3.

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.

Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Lindahl GE, Renzoni EA.

Thorax. 2013 May;68(5):436-41. doi: 10.1136/thoraxjnl-2012-201786. Epub 2013 Jan 15.

PMID:
23321605
4.

The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.

Peljto AL, Steele MP, Fingerlin TE, Hinchcliff ME, Murphy E, Podlusky S, Carns M, Schwarz M, Varga J, Schwartz DA.

Chest. 2012 Dec;142(6):1584-8. doi: 10.1378/chest.12-0110.

5.

Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.

Wang C, Zhuang Y, Guo W, Cao L, Zhang H, Xu L, Fan Y, Zhang D, Wang Y.

PLoS One. 2014 Aug 14;9(8):e104919. doi: 10.1371/journal.pone.0104919. eCollection 2014.

6.

A common MUC5B promoter polymorphism and pulmonary fibrosis.

Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, Evans CM, Garantziotis S, Adler KB, Dickey BF, du Bois RM, Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Park J, Crews AL, Slifer SH, Auerbach S, Roy MG, Lin J, Hennessy CE, Schwarz MI, Schwartz DA.

N Engl J Med. 2011 Apr 21;364(16):1503-12. doi: 10.1056/NEJMoa1013660.

7.

The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.

Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, Cadranel J, Cottin V, Gazal S, Peljto AL, Varga J, Schwartz DA, Valeyre D, Grandchamp B.

PLoS One. 2013 Aug 5;8(8):e70621. doi: 10.1371/journal.pone.0070621. Print 2013. Review.

8.

Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.

Wei R, Li C, Zhang M, Jones-Hall YL, Myers JL, Noth I, Liu W.

Transl Res. 2014 May;163(5):494-502. doi: 10.1016/j.trsl.2013.12.006. Epub 2013 Dec 17.

9.

Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background.

Borie R, Kannengiesser C, Crestani B.

Curr Opin Pulm Med. 2012 Sep;18(5):455-61. doi: 10.1097/MCP.0b013e328356b15c. Review.

PMID:
22781209
10.

MUC5B: a good target for future therapy in pulmonary fibrosis?

Mahida R, Turner AM.

Thorax. 2013 May;68(5):401. doi: 10.1136/thoraxjnl-2012-202957. Epub 2013 Jan 17. No abstract available.

PMID:
23329274
11.

MUC5B promoter polymorphism and interstitial lung abnormalities.

Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, Nishino M, Araki T, Zazueta OE, Kurugol S, Ross JC, San José Estépar R, Murphy E, Steele MP, Loyd JE, Schwarz MI, Fingerlin TE, Rosas IO, Washko GR, O'Connor GT, Schwartz DA.

N Engl J Med. 2013 Jun 6;368(23):2192-200. doi: 10.1056/NEJMoa1216076. Epub 2013 May 21.

12.

A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.

Lee MG, Lee YH.

Inflamm Res. 2015 Jun;64(6):463-70. doi: 10.1007/s00011-015-0829-6. Epub 2015 Apr 30. Review.

PMID:
25926289
13.

MUC5B and Idiopathic Pulmonary Fibrosis.

Yang IV, Fingerlin TE, Evans CM, Schwarz MI, Schwartz DA.

Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S193-9. doi: 10.1513/AnnalsATS.201503-110AW.

14.

Inherited interstitial lung disease.

Garcia CK, Raghu G.

Clin Chest Med. 2004 Sep;25(3):421-33, v. Review. Erratum in: Clin Chest Med. 2004 Dec;25(4):xi.

PMID:
15331184
15.

MUC5B promoter polymorphism and pulmonary fibrosis.

Burch LH.

N Engl J Med. 2011 Jul 14;365(2):178; author reply 178-9. doi: 10.1056/NEJMc1105707#SA2. No abstract available.

PMID:
21751916
16.

Bedside to gene and back in idiopathic pulmonary fibrosis.

Cookson WO, Moffatt MF.

N Engl J Med. 2013 Jun 6;368(23):2228-30. doi: 10.1056/NEJMe1304758. Epub 2013 May 21. No abstract available.

PMID:
23692168
17.

Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.

Verleden GM, du Bois RM, Bouros D, Drent M, Millar A, Müller-Quernheim J, Semenzato G, Johnson S, Sourvino G, Olivier D, Pietinalho A, Xaubet A.

Eur Respir J Suppl. 2001 Sep;32:17s-29s. Review.

18.

Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis.

Margaritopoulos GA, Romagnoli M, Poletti V, Siafakas NM, Wells AU, Antoniou KM.

Eur Respir Rev. 2012 Mar 1;21(123):48-56. doi: 10.1183/09059180.00007611. Review.

19.

Genetics and early detection in idiopathic pulmonary fibrosis.

Putman RK, Rosas IO, Hunninghake GM.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):770-8. doi: 10.1164/rccm.201312-2219PP. Review.

20.

Sarcoidosis and interstitial pulmonary fibrosis; two distinct disorders or two ends of the same spectrum.

Shigemitsu H, Azuma A.

Curr Opin Pulm Med. 2011 Sep;17(5):303-7. doi: 10.1097/MCP.0b013e3283486d52. Review.

PMID:
21681100

Supplemental Content

Support Center